RHYTHM PHARMACEUTICALS INC (RYTM) — institutional ownership
318 funds reported holding RHYTHM PHARMACEUTICALS INC in their latest 13F filings, worth $9.34B in total (CUSIP 76243J105).
Largest holders
- RA CAPITAL MANAGEMENT, L.P. — $740M
- BlackRock, Inc. (BLK) — $684M
- VANGUARD GROUP INC — $665M
- BAKER BROS. ADVISORS LP — $622M
- PRIMECAP MANAGEMENT CO/CA/ — $352M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $348M
- VANGUARD CAPITAL MANAGEMENT LLC — $334M
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $292M
- PERCEPTIVE ADVISORS LLC — $287M
- STATE STREET CORP (STT, STT-PG) — $286M
Famous investors holding it
- Ken Griffin portfolio (Citadel Advisors)
- Izzy Englander portfolio (Millennium Management)
- Stanley Druckenmiller portfolio (Duquesne Family Office)
- Renaissance Technologies portfolio (Renaissance Technologies)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Two Sigma portfolio (Two Sigma Investments)